Sees FY24 EBITDA adjusted at EUR 1.8B+ including Biotest.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on GRFS:
- GRFS Earnings this Week: How Will it Perform?
- Grifols price target raised to EUR 19.40 from EUR 18.60 at Berenberg
- Grifols announces FC from Biotest met primary endpoint
- Grifols announces positive topline phase 3 fibrinogen clinical trial results
- Grifols names Nacho Abia CEO, transitions for CCO, COO
